iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data
October 26, 2023 Safety of Philips’ iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking science at TCT 2023 highlighting patient-level outcomes analysis of 42,000 patients from the National Swedeheart Quality Registry Previous data demonstrate that iFR delivers consistent patient outcomes, reduces discomfort and offers a more cost-effective and […]